Show simple item record

dc.contributor.authorSundahl, N.
dc.contributor.authorGillessen, Silke
dc.contributor.authorSweeney, C.
dc.contributor.authorOst, P.
dc.date.accessioned2020-10-06T13:33:49Z
dc.date.available2020-10-06T13:33:49Z
dc.date.issued2020en
dc.identifier.citationSundahl N, Gillessen S, Sweeney C, Ost P. When What You See Is Not Always What You Get: Raising the Bar of Evidence for New Diagnostic Imaging Modalities. Eur Urol. 2020.en
dc.identifier.pmid32847699en
dc.identifier.doi10.1016/j.eururo.2020.07.029en
dc.identifier.urihttp://hdl.handle.net/10541/623348
dc.description.abstractEven though prostate-specific membrane antigen (PSMA)-positron emission tomography (PET)-computed tomography (CT) is more accurate than conventional imaging in prostate cancer patients, its impact on patient-relevant outcomes is unknown. We argue that more evidence is required before using PSMA-PET-CT as the standard of care for staging.en
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1016/j.eururo.2020.07.029en
dc.titleWhen what you see is not always what you get: raising the bar of evidence for new diagnostic imaging modalitiesen
dc.typeArticleen
dc.contributor.departmentDepartment of Radiation Oncology, Ghent University Hospital, Ghent, Belgium; Division of Radiotherapy and Imaging, Institute of Cancer Research, London, UK. Electronic address: nora.sundahl@ugent.be.en
dc.identifier.journalEuropean Urologyen
dc.description.noteen]


Files in this item

This item appears in the following Collection(s)

Show simple item record